Medical treatment of missed abortion using misoprostol

Int J Gynaecol Obstet. 2004 Nov;87(2):138-42. doi: 10.1016/j.ijgo.2004.07.015.

Abstract

Objective: To compare the efficacy of two routes of misoprostol administration (oral and vaginal) for treatment of missed abortion.

Methods: Two hundred women with confirmed missed abortion received 800 mcg misoprostol either orally or vaginally. All women returned for follow-up care 2 days later. If the pregnancy was not completely evacuated at this time, women could wait an additional 5 days or undergo immediate surgical completion. Efficacy was defined as the percent of women discharged from the study without need for surgical intervention.

Results: Efficacy was high in both groups and not statistically different (oral=89.0%, vaginal=92.9%). While the groups did not differ in terms of the completion rate by day 2 (oral=41.6%, vaginal=52.7%), the mean time to expulsion was longer (21.04 h) in the oral group than the vaginal group (13.47 h), p=0.041. Women in both groups were highly satisfied with the method.

Conclusions: Medical management of missed abortion with either oral or vaginal misoprostol is highly effective and highly acceptable.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortifacient Agents, Nonsteroidal / administration & dosage*
  • Abortion, Missed / drug therapy*
  • Abortion, Missed / pathology
  • Administration, Intravaginal
  • Administration, Oral
  • Adult
  • Female
  • Humans
  • Middle Aged
  • Misoprostol / administration & dosage*
  • Pregnancy
  • Pregnancy Trimester, First
  • Treatment Outcome

Substances

  • Abortifacient Agents, Nonsteroidal
  • Misoprostol